168. Ehlers-Danlos syndrome Disease details / Clinical trials / Drug dev / DR info

Bupivacaine Injection
   Vanderbilt University Medical Center
      2019   -   NCT04036305   United States;
Celiprolol
   Assistance Publique - Hôpitaux de Paris
      2003   Phase 4   NCT00190411   France;
Control
   Assistance Publique - Hôpitaux de Paris
      2003   Phase 4   NCT00190411   France;
Irbesartan
   Assistance Publique - Hôpitaux de Paris
      2016   Phase 3   NCT02597361   France;
Kera-X
   Hadassah Medical Organization
      2008   -   NCT01307527   Israel;
Lidocaine Injection
   Vanderbilt University Medical Center
      2019   -   NCT04036305   United States;
Mecasermin
   Bispebjerg Hospital
      2011   -   NCT01446783   Denmark;
Mind-body therapy
   National Human Genome Research Institute (NHGRI)
      2000   Phase 2   NCT00001966   United States;
Oxygen
   Hospital St. Joseph, Marseille, France
      2021   Phase 4   NCT04890431   -
Riboflavin
   Hadassah Medical Organization
      2008   -   NCT01307527   Israel;
Saline
   Bispebjerg Hospital
      2011   -   NCT01446783   Denmark;
Sodium Chloride Injection
   Vanderbilt University Medical Center
      2019   -   NCT04036305   United States;